Your browser doesn't support javascript.
loading
The systemic treatment of recurrent ovarian cancer revisited.
Baert, T; Ferrero, A; Sehouli, J; O'Donnell, D M; González-Martín, A; Joly, F; van der Velden, J; Blecharz, P; Tan, D S P; Querleu, D; Colombo, N; du Bois, A; Ledermann, J A.
Afiliación
  • Baert T; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany; Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: thais.baert@gmail.com.
  • Ferrero A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, Mauriziano Hospital, Turin, Italy.
  • Sehouli J; Department of Gynecology with Center for Oncological Surgery, Charité-University hospital Berlin, Berlin, Germany.
  • O'Donnell DM; Department of Oncology, St. James's Hospital, Dublin, Ireland.
  • González-Martín A; Medical Oncology Department, Clínica Universidad de Navarra University Hospital, Madrid, Spain.
  • Joly F; Department of Oncology, Centre Francois Baclesse, Caen, France.
  • van der Velden J; Department of Medical Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Blecharz P; Department of Gynecologic Oncology, Center of Oncology, M. Sklodowska-Curie Institute, Krakow, Poland.
  • Tan DSP; Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Querleu D; Department of Surgical Oncology, Institut Bergonié, Bordeaux, France.
  • Colombo N; Department of Medicine and Surgery, European Institute of Oncology IRCCS, Milan, Italy; University of Milan-Bicocca, Milan, Italy.
  • du Bois A; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany.
  • Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
Ann Oncol ; 32(6): 710-725, 2021 06.
Article en En | MEDLINE | ID: mdl-33675937

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article